|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Land and improvements | ||||||||||||||||||||
| Building and improvements | ||||||||||||||||||||
| Tenant improvements | ||||||||||||||||||||
| Furniture, fixtures and equipment | ||||||||||||||||||||
| Real estate under development | ||||||||||||||||||||
| Total investment in real estate | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Investment in real estate, net | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Tenant and other receivables, net of allowance for doubtful accounts of $296 and $317, respectively | ||||||||||||||||||||
| Deferred rent | ||||||||||||||||||||
| Deferred costs and intangible assets, net | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Assets Held for Sale | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Notes payable, net of unamortized loan costs of $7,178 and $8,712, respectively | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Security deposits | ||||||||||||||||||||
| Below-market leases, net | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Liabilities Held for Sale | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Equity (Deficit): | ||||||||||||||||||||
| Preferred stock, $0.01 par value; 100,000 shares authorized (including 140 shares of 12.5% Series A cumulative non-voting preferred stock), zero shares issued and outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value; 500,000,000 shares authorized, 16,157,566 and 16,146,546 shares issued and outstanding, at June 30, 2026, and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity (deficit) | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| TOTAL EQUITY (DEFICIT) | ||||||||||||||||||||
| TOTAL LIABILITIES AND EQUITY (DEFICIT) |
Loading...
